Robust scientific research is necessary to provide continued hope for all those diagnosed with lung cancer. LUNGevity's Translational Science Research Program—focused on the second stage of research—aims to take knowledge from basic discovery and apply it to the treatment of disease to give patients access in a clinical setting more quickly.

LUNGevity’s strategic approach to research falls into two priority areas: finding lung cancer early and treating it more effectively. There are LUNGevity award programs to support researchers from postdoctoral fellows through established investigators to harness skill and innovative ideas at all levels.

Research projects are carefully vetted to ensure that we are funding the most impactful science possible. The review process includes a formal study section with Scientific Advisory Board members and other lung cancer experts who identify, among the grant applications we receive, the most promising proposals for research into the early detection and treatment of lung cancer. The lung cancer experts who review the grant applications assess them on a number of measures, including the likelihood that the proposed research will exert a sustained, powerful influence on the research field involved and have a near-term impact on improving lung cancer mortality rates.

LUNGevity strategically adds new award vehicles to leverage and enhance scientific advancements: 

History of LUNGevity's research awards programs

Impact of LUNGevity Research

LUNGevity funds research that is patient-centered, drives the science of cancer research, and is sustainable

Translational Science Research Programs

Supporting the next generation of lung cancer researchers and funding the most impactful science possible

Applying for a LUNGevity Award

Complete information for researchers wishing to apply for a LUNGevity grant

Funded Projects

View our funded research projects by year and search the research database